Analyst Salveen Richter downgraded shares of the biotech company from neutral to buy and significantly lowered her price target.
MicroStrategy is a buy that can gain more than 50% from here, Mizuho says
The firm initiated the stock with an outperform rating and $515 price target.
Wednesday’s big stock stories: What’s likely to move the market in the next trading session
The S&P 500 and the Nasdaq Composite rose on Tuesday as investors snapped up tech shares. Here’s what’s on CNBC’s radar going into Wednesday.
There’s still value for Nvidia despite DeepSeek threat, says strategist Jay Woods
Jay Woods of Freedom Capital Markets joined CNBC’s “Power Lunch” on Tuesday to offer his take on three key market movers.
Big interest income in 2024 leads to hefty taxes in April. Prepare for tax filing season
Certificates of deposit and high-yield savings accounts paid out handsomely in 2024, but investors now face the tax bill.
DeepSeek AI breakthrough calls for a rethink on Chinese equities, investors say
DeepSeek might underscore overlooked opportunities in Chinese stocks, according to investors.
This tech stock hurt in the AI sell-off is primed for another breakout, according to the charts
Todd Gordon breaks down the charts on Applovin.
Ron Insana: Consider adding exposure to Europe as U.S. stocks face the risk of a correction
A correction could be in the cards for U.S. stocks, and some exposure to Europe could help investors manage the risk, Ron Insana says.
A hedge on Tesla in case earnings this week show Musk is more focused on DC than EV maker
Mike Khouw describes a put spread on Tesla.
There’s more market pain to come near term, says Canaccord Genuity
Investors’ confidence in the artificial intelligence trade is being tested this week, and more pressure could still be ahead.